MBA, CEO, Life Length
Stephen Matlin is Chairman and CEO as well as a founding shareholder of Life Length, the world’s leader in the life science sector for telomere diagnostics and Spain’s only U.S. Federally certified “CLIA” and ISO 15189 accredited laboratory. He has led the Company since inception and assisted in establishing the company as the world leader in telomere measurements and diagnostics. He is an American entrepreneur, with a background in finance and strategy, who worked in investment banking and strategy consultancy for over twenty years. He received his undergraduate degree from Dartmouth College and an MBA from Harvard Business School.
Telomeres: Unlocking The Aging Code
The field of telomere research has been growing at an unprecedented rate. Telomere testing is emerging as a valuable clinical tool to help guide treatment decisions. Either independently, or along with other biomarkers, telomere testing can provide insights into early disease detection, risk stratification, and prognostic assessment.